Holen Sie sich die Stockscreener-App
9.75
0.52%
0.05
Handel nachbörslich:
9.56
-0.19
-1.95%
Schlusskurs vom Vortag:
$9.70
Offen:
$9.86
24-Stunden-Volumen:
480.41K
Relative Volume:
0.75
Marktkapitalisierung:
$902.59M
Einnahmen:
$81.39M
Nettoeinkommen (Verlust:
$-114.20M
KGV:
-6.8407
EPS:
-1.4253
Netto-Cashflow:
$-50.60M
1W Leistung:
+7.38%
1M Leistung:
+6.21%
6M Leistung:
+13.64%
1J Leistung:
+51.16%
1-Tages-Spanne:
$9.63
$10.08
1-Wochen-Bereich:
$8.75
$10.08
52-Wochen-Spanne:
$4.55
$11.85
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Firmenname
Meiragtx Holdings Plc
Sektor
Branche
Telefon
646-860-7985
Adresse
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
9.75 | 897.96M | 81.39M | -114.20M | -50.60M | -1.4253 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2024-07-31 | Fortgesetzt | Chardan Capital Markets | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-09-15 | Fortgesetzt | BofA Securities | Buy |
| 2019-09-03 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-02-27 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-07-03 | Eingeleitet | Barclays | Overweight |
| 2018-07-03 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Meiragtx Holdings Plc Aktie (MGTX) Neueste Nachrichten
Will MeiraGTx Holdings PLC (MGTX) report negative Q1 earnings? What you should know - MSN
Will MeiraGTx Holdings PLC (MGTX) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
MeiraGTx Holdings plc ($MGTX) President and CEO 2025 Pay Revealed - Quiver Quantitative
[ARS] MeiraGTx Holdings plc SEC Filing - Stock Titan
MeiraGTx (NASDAQ: MGTX) details pay and board votes for 2026 AGM - Stock Titan
MeiraGTx (MGTX) CMO amends Form 4 for 7,814 tax-withheld shares - Stock Titan
MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? - MSN
MeiraGTx rises on upcoming phase 1 readout for gene therapy - MSN
DAVENPORT & Co LLC Purchases 7,000 Shares of MeiraGTx Holdings Plc (NASDAQ:MGTX) - 富途牛牛
Discipline and Rules-Based Execution in MGTX Response - Stock Traders Daily
Eli Lilly partner MeiraGTx regains rights for genetic eye disease drug from Johnson & Johnson - MSN
MeiraGTx Holdings PLC (MGTX) Q4 earnings and revenues surpass estimates - MSN
Here is Why MeiraGTx Holdings (MGTX) is One of the Best Growth Stocks Under $10 - Yahoo Finance
Perceptive lifts MeiraGTx (NASDAQ: MGTX) ownership to 12.6% with warrants - Stock Titan
MeiraGTx and Hologen Enter Material Definitive Agreements and Collaboration License for Neuro AI – April 2026 - Minichart
MeiraGTx and Hologen finalize collaboration and licensing agreements By Investing.com - Investing.com Nigeria
MeiraGTx and Hologen finalize collaboration and licensing agreements - Investing.com
MeiraGTx acquires J&J's XLRP investigational therapy - Eyes On Eyecare
MeiraGTx (NASDAQ: MGTX) details $200M Hologen CNS gene therapy pact - Stock Titan
MeiraGTx (MGTX) Perceptive funds gain $8 warrants and new shares - Stock Titan
Piper Sandler raises MeiraGTx stock price target to $30 on data By Investing.com - Investing.com Australia
MGTX Maintained by Piper Sandler -- Price Target Raised to $30 - GuruFocus
Piper Sandler raises MeiraGTx stock price target to $30 on data - Investing.com UK
MeiraGTx (NASDAQ:MGTX) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
What is HC Wainwright's Forecast for MeiraGTx Q1 Earnings? - MarketBeat
Piper Sandler Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $30 - Moomoo
MGTX SEC FilingsMeiragtx Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Richard Giroux Sells 56,000 Shares of MeiraGTx (NASDAQ:MGTX) Stock - MarketBeat
MeiraGTx CFO & COO Richard Giroux sells $572,320 in stock By Investing.com - Investing.com South Africa
MeiraGTx CFO & COO Richard Giroux sells $572,320 in stock - Investing.com
[144] MeiraGTx Holdings plc SEC Filing - Stock Titan
MeiraGTx (MGTX) CFO sells 56,000 shares under 10b5-1 plan - Stock Titan
Genetic Medicines Co. Reveals Transformative 'Only-of-Its-Kind' AAV Therapy Milestone - Streetwise Reports
Latham & Watkins Represents MeiraGTx in US$100 Million Ordinary Shares Offering - Latham & Watkins LLP
MEIRAGTX HOLDINGS PLC : COMPANY ANNOUNCEMENT - marketscreener.com
H.C. Wainwright reiterates MeiraGTx stock rating on gene therapy progress By Investing.com - Investing.com India
H.C. Wainwright reiterates MeiraGTx stock rating on gene therapy progress - Investing.com
MeiraGTx (MGTX) Soars 6.8%: Is Further Upside Left in the Stock? - Yahoo Finance
H.C. Wainwright Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $20 - Moomoo
MeiraGTx Announces Public Equity Offering to Fund Growth - The Globe and Mail
MGTX Maintained by RBC Capital -- Price Target Raised to $24.00 - GuruFocus
Finanzdaten der Meiragtx Holdings Plc-Aktie (MGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):